Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-12-20

FDA Approved: IRINOTECAN HYDROCHLORIDE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved the original application for irinotecan hydrochloride injection as a generic drug (ANDA) from Hikma Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IRINOTECAN HYDROCHLORIDE (irinotecan hydrochloride)

Snippet

ORIG AP for IRINOTECAN HYDROCHLORIDE (IRINOTECAN HYDROCHLORIDE)